The Academy of Managed Care Pharmacy Format for Formulary Submissions: an evolving standard--a Foundation for Managed Care Pharmacy Task Force report.
OBJECTIVE
The objective of this report is to provide, in detail, the evidentiary requirements contained in Version 2.0 of the Academy of Managed Care Pharmacy's (AMCP's) Format for Formulary Submissions and to elaborate on several key issues regarding the use of the Format that users, potential users, and pharmaceutical manufacturers have raised since AMCP published the first version of the guidelines in October 2000.


BACKGROUND
The AMCP published its Format for Formulary Submissions in October 2000. The AMCP leadership and its members were motivated to develop these guidelines by a growing need to ensure that any increased utilization of medications, biopharmaceuticals, and vaccine products was appropriate and that newer products would bring added clinical and economic value to covered populations. Since publication of the Format, it has garnered nationwide publicity and attracted considerable positive and negative attention. As adoption of the AMCP Format has spread, manufacturers have begun to standardize the framework within which they present population-specific data. Since publication of the AMCP Format, the AMCP and the Foundation for Managed Care Pharmacy (FMCP) have continuously sought input from pharmaceutical manufacturers and health-system pharmacists through various venues to improve and clarify the process. Version 2.0 is the first attempt to address user's comments and concerns.


METHODS
The majority of the article text is taken directly from Version 2.0 of the AMCP Format for Formulary Submissions published by the AMCP in October 2002.


CONCLUSIONS
The AMCP and the FMCP believe that the AMCP Format is a tool that will help health systems establish a record of commitment to rational decision making, thus gaining the confidence of patients, clinicians, and members. While providing manufacturers a vehicle for communicating the scientifically based value of their product to a health system, the required evidence to substantiate that value argument allows a pharmacy and therapeutics committee to determine the clinical benefits of a drug, verify any cost savings the drug may generate, and determine the overall cost consequences to their health system. The AMCP Format for Formulary Submissions is an essential tool to evaluate medications, but requires thoughtful consideration as it is used.
Fry
Richard N
RN
Foundation for Managed Care Pharmacy, Alexandria,VA 22314, USA. rfry@fmcpnet.org
Avey
Steven G
SG
Sullivan
Sean D
SD
D000047:Academies and Institutes; D026683:Advisory Committees; D003142:Communication; D003219:Confidentiality; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004341:Drug Evaluation; D004345:Drug Industry; D005069:Evaluation Studies as Topic; D019317:Evidence-Based Medicine; D005568:Forms and Records Control / Q000592:standards*; D005569:Formularies as Topic / Q000592:standards*; D017408:Guidelines as Topic; D006801:Humans; D019458:Insurance Coverage; D008329:Managed Care Programs / Q000191:economics / Q000458:organization & administration* / Q000592:standards; D014481:United States; D014486:United States Food and Drug Administration